UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

The road to a more effective influenza vaccine: Up to date studies and future prospects

Vaccine, 2017-09, Vol.35 (40), p.5388-5395

2017

Volltextzugriff (PDF)

Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus

Vaccine, 2017-09, Vol.35 (39), p.5297-5302

2017

Volltextzugriff (PDF)

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees

Emerging infectious diseases, 2022-05, Vol.28 (5), p.998-1001

2022

Volltextzugriff (PDF)

Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus

Proceedings of the National Academy of Sciences - PNAS, 2015-06, Vol.112 (25), p.7809-7814

2015

Volltextzugriff (PDF)

Identification and characterization of a novel Enterococcus bacteriophage with potential to ameliorate murine colitis

Scientific reports, 2021-10, Vol.11 (1), p.20231-20231, Article 20231

2021

Volltextzugriff (PDF)

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics

Expert review of vaccines, 2018-08, Vol.17 (8), p.687-696

2018

Volltextzugriff (PDF)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine

Microbiology and immunology, 2020-04, Vol.64 (4), p.313-325

2020

Volltextzugriff (PDF)

Robust production of IL-33 and TSLP by lung endothelial cells in response to low-dose dsRNA stimulation

Journal of allergy and clinical immunology, 2020-12, Vol.146 (6), p.1449-1452.e2

2020

Volltextzugriff (PDF)

Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

Japanese Journal of Infectious Diseases, 2016, Vol.69(3), pp.165-179

2016

Volltextzugriff (PDF)

Combatting infectious diseases; nanotechnology as a platform for rational vaccine design

Advanced drug delivery reviews, 2014-07, Vol.74, p.28-34

2014

Volltextzugriff (PDF)

IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody

PLoS pathogens, 2019-01, Vol.15 (1), p.e1007427-e1007427

2019

Volltextzugriff (PDF)

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021-01, Vol.27 (1), p.120-122

2021

Volltextzugriff (PDF)

Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies

Nature communications, 2019-08, Vol.10 (1), p.3883-13, Article 3883

2019

Volltextzugriff (PDF)

Histological characteristics of matrix metalloproteinase‐9 and tissue inhibitor of metalloproteinases‐1 in asthmatic murine model during A(H1N1)pdm09 infection

Pathology international, 2022-10, Vol.72 (10), p.506-518

2022

Volltextzugriff (PDF)

Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate

Viral immunology, 2017-07, Vol.30 (6), p.451

2017

Volltextzugriff (PDF)

Outer membrane vesicles of Porphyromonas gingivalis elicit a mucosal immune response

PloS one, 2011-10, Vol.6 (10), p.e26163-e26163

2011

Volltextzugriff (PDF)

Inefficient Tax-Specific T-Cell Responses in Mice after Syngeneic Transplantation with tax-Transgenic Mouse-Derived Adult T-Cell Leukemia Cells

Japanese Journal of Infectious Diseases, 2020/05/29, Vol.73(3), pp.221-225

2020

Volltextzugriff (PDF)

Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

Scientific reports, 2024-01, Vol.14 (1), p.2599-2599, Article 2599

2024

Volltextzugriff (PDF)

Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection

PloS one, 2017-02, Vol.12 (2), p.e0173008-e0173008

2017

Volltextzugriff (PDF)

The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine

Vaccine, 2016-02, Vol.34 (9), p.1201-1207

2016

Volltextzugriff (PDF)

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

Scientific reports, 2022-12, Vol.12 (1), p.20861-20861, Article 20861

2022

Volltextzugriff (PDF)

Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study

Journal of anesthesia, 2021-10, Vol.35 (5), p.638-645

2021

Volltextzugriff (PDF)

A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection

Science advances, 2022-01, Vol.8 (1), p.eabh3827-eabh3827

2022

Volltextzugriff (PDF)

An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody

PloS one, 2021-01, Vol.16 (1), p.e0245244-e0245244

2021

Volltextzugriff (PDF)

Protective antibody responses against A(H1N1)pdm09 primed by infection and recalled by intranasal vaccination

Vaccine, 2015-11, Vol.33 (45), p.6066-6069

2015

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(92)

Sprache

Englisch
(89)
Japanisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(50)
Humans
(36)
Animals
(33)
Immunology
(29)
Influenza
(29)
Viruses
(26)
Infectious Diseases
(25)
Mice
(25)
Infections
(23)
Vaccines
(23)
Influenza Virus
(17)
Multidisciplinary Sciences
(16)
Science & Technology - Other Topics
(16)
Influenza Vaccines - Immunology
(15)
Administration, Intranasal
(13)
Female
(13)
Antibodies
(12)
Immune Response
(12)
Immunoglobulin A
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The road to a more effective influenza vaccine: Up to date studies and future prospects

Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees

Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus

Identification and characterization of a novel Enterococcus bacteriophage with potential to ameliorate murine colitis

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine

Robust production of IL-33 and TSLP by lung endothelial cells in response to low-dose dsRNA stimulation

Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?

Combatting infectious diseases; nanotechnology as a platform for rational vaccine design

IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers

Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies

Histological characteristics of matrix metalloproteinase‐9 and tissue inhibitor of metalloproteinases‐1 in asthmatic murine model during A(H1N1)pdm09 infection

Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate

Outer membrane vesicles of Porphyromonas gingivalis elicit a mucosal immune response

Inefficient Tax-Specific T-Cell Responses in Mice after Syngeneic Transplantation with tax-Transgenic Mouse-Derived Adult T-Cell Leukemia Cells

Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection

The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study

A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection

An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody

Protective antibody responses against A(H1N1)pdm09 primed by infection and recalled by intranasal vaccination

Suchergebnisse filtern